Two-port Video-Assisted Thoracoscopic Plication Using Porous Nitinol Pledgets for Diaphragmatic Paralysis.

IF 2.2 4区 医学 Q3 SURGERY
Evgeniy Topolnitskiy, Timofey Chekalkin, Ekaterina Marchenko, Ji-Hoon Kang
{"title":"Two-port Video-Assisted Thoracoscopic Plication Using Porous Nitinol Pledgets for Diaphragmatic Paralysis.","authors":"Evgeniy Topolnitskiy, Timofey Chekalkin, Ekaterina Marchenko, Ji-Hoon Kang","doi":"10.1177/15533506261455435","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundDiaphragmatic plication is a standard treatment for symptomatic unilateral diaphragmatic paralysis, but the best minimally invasive technique and reinforcement material remain debated. We evaluated a two-port VATS plication technique using porous Nitinol pledgets.MethodsThis retrospective single-center study included 30 consecutive adults with symptomatic unilateral diaphragmatic paralysis who underwent two-port VATS plication between 2018 and 2024. All procedures were performed using porous NiTi pledgets (7 × 5 × 3 mm) and non-absorbable sutures. Perioperative outcomes included operative time, blood loss, extubation, ICU use, chest tube duration, pain scores, complications, and length of stay. Functional outcomes comprised spirometry (FVC, FEV1), MRC dyspnea scores, and radiographic hemidiaphragm elevation at 1, 6, and 12 months.ResultsMean age was 61.3 ± 10.3 years; 66.7% of patients were female. Mean operative time was 123.1 ± 29.0 min and blood loss 20.3 ± 20.8 mL. Immediate extubation occurred in 86.7%; 40% required brief ICU monitoring. Chest tube duration and hospital stay were 2.2 ± 1.3 and 5.5 ± 2.9 days. Complications occurred in 13.3%, all grade I-II. At 12 months, FVC increased from 60.2 ± 12.2% to 82.1 ± 10.6%, FEV1 from 60.2 ± 14.5% to 81.1 ± 11.8%, MRC score improved from 3.8 ± 0.4 to 0.5 ± 0.6, diaphragm elevation decreased by ∼34%, and 90% of patients reported symptomatic improvement.ConclusionsTwo-port VATS diaphragmatic plication reinforced with porous NiTi pledgets demonstrates feasibility, safety, and reproducibility with sustained functional and symptomatic improvement and low morbidity. The absence of a control group precludes claims of material superiority; observed benefits primarily reflect the mechanical restoration achieved by plication itself, with porous NiTi serving as a biocompatible alternative to standard PTFE pledgets.</p>","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"15533506261455435"},"PeriodicalIF":2.2000,"publicationDate":"2026-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Innovation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15533506261455435","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundDiaphragmatic plication is a standard treatment for symptomatic unilateral diaphragmatic paralysis, but the best minimally invasive technique and reinforcement material remain debated. We evaluated a two-port VATS plication technique using porous Nitinol pledgets.MethodsThis retrospective single-center study included 30 consecutive adults with symptomatic unilateral diaphragmatic paralysis who underwent two-port VATS plication between 2018 and 2024. All procedures were performed using porous NiTi pledgets (7 × 5 × 3 mm) and non-absorbable sutures. Perioperative outcomes included operative time, blood loss, extubation, ICU use, chest tube duration, pain scores, complications, and length of stay. Functional outcomes comprised spirometry (FVC, FEV1), MRC dyspnea scores, and radiographic hemidiaphragm elevation at 1, 6, and 12 months.ResultsMean age was 61.3 ± 10.3 years; 66.7% of patients were female. Mean operative time was 123.1 ± 29.0 min and blood loss 20.3 ± 20.8 mL. Immediate extubation occurred in 86.7%; 40% required brief ICU monitoring. Chest tube duration and hospital stay were 2.2 ± 1.3 and 5.5 ± 2.9 days. Complications occurred in 13.3%, all grade I-II. At 12 months, FVC increased from 60.2 ± 12.2% to 82.1 ± 10.6%, FEV1 from 60.2 ± 14.5% to 81.1 ± 11.8%, MRC score improved from 3.8 ± 0.4 to 0.5 ± 0.6, diaphragm elevation decreased by ∼34%, and 90% of patients reported symptomatic improvement.ConclusionsTwo-port VATS diaphragmatic plication reinforced with porous NiTi pledgets demonstrates feasibility, safety, and reproducibility with sustained functional and symptomatic improvement and low morbidity. The absence of a control group precludes claims of material superiority; observed benefits primarily reflect the mechanical restoration achieved by plication itself, with porous NiTi serving as a biocompatible alternative to standard PTFE pledgets.

双端口视频胸腔镜应用多孔镍钛诺材料治疗膈肌麻痹。
背景:膈肌应用术是治疗单侧膈肌麻痹的标准方法,但最佳的微创技术和增强材料仍存在争议。我们评估了一种使用多孔镍钛诺材料的双端口VATS应用技术。方法本回顾性单中心研究纳入了30例连续的有症状的单侧膈肌麻痹的成年人,他们在2018年至2024年间接受了双端口VATS应用。所有手术均采用多孔NiTi质材(7 × 5 × 3 mm)和不可吸收缝线进行。围手术期结果包括手术时间、出血量、拔管、ICU使用、胸管持续时间、疼痛评分、并发症和住院时间。功能指标包括肺活量测定(FVC、FEV1)、MRC呼吸困难评分和1、6和12个月时的横膈膜升高。结果患者平均年龄61.3±10.3岁;66.7%的患者为女性。平均手术时间123.1±29.0 min,出血量20.3±20.8 mL,即刻拔管占86.7%;40%需要短暂的ICU监护。胸管时间(2.2±1.3)天和住院时间(5.5±2.9)d。并发症发生率为13.3%,均为I-II级。在12个月时,FVC从60.2±12.2%增加到82.1±10.6%,FEV1从60.2±14.5%增加到81.1±11.8%,MRC评分从3.8±0.4提高到0.5±0.6,膈膜抬高降低了~ 34%,90%的患者报告症状改善。结论多孔钛膜增强双孔VATS膈肌应用具有可行性、安全性和可重复性,功能和症状持续改善,发病率低。控制组的缺失排除了物质优势的主张;观察到的好处主要反映了应用本身实现的机械修复,多孔NiTi作为标准PTFE质材的生物相容性替代品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Surgical Innovation
Surgical Innovation 医学-外科
CiteScore
2.90
自引率
0.00%
发文量
72
审稿时长
6-12 weeks
期刊介绍: Surgical Innovation (SRI) is a peer-reviewed bi-monthly journal focusing on minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies. SRI prepares surgeons to think and work in "the operating room of the future" through learning new techniques, understanding and adapting to new technologies, maintaining surgical competencies, and applying surgical outcomes data to their practices. This journal is a member of the Committee on Publication Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书